Convelo Therapeutics

Cleveland, United States

Convelo Therapeutics specializes in developing medicines to regenerate myelin around nerve cells and restore function

$10.8M raised

Dec 2022

Venture - Series Unknown

Biotechnology Health Care Therapeutics

Top Investors

Zanite Ventures

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Convelo Therapeutics

How much funding has Convelo Therapeutics raised?

Convelo Therapeutics has raised $10.8M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in December 2022.

Who are Convelo Therapeutics's investors?

Convelo Therapeutics's investors include Zanite Ventures.

Where is Convelo Therapeutics headquartered?

Convelo Therapeutics is headquartered in Cleveland, United States.

What does Convelo Therapeutics do?

Convelo Therapeutics specializes in developing medicines to regenerate myelin around nerve cells and restore function

What stage is Convelo Therapeutics at?

Convelo Therapeutics is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated December 8, 2022.

MLA

"Convelo Therapeutics — Funding & Investors." VCBacked, December 8, 2022, https://www.vcbacked.co/company/convelo-therapeutics. Accessed July 2, 2026.

APA

VCBacked. (2022). Convelo Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/convelo-therapeutics

Wikipedia (cite web)

{{cite web |title=Convelo Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/convelo-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated December 8, 2022.